Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02069613 · ClinicalTrials.gov registry record

Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)

A clinical trial of Concussion, Mild, sponsored by Huntington Medical Research Institutes.

Completed
Registry status
44
Enrollment target
3
Study locations

NCT02069613 is a study of Concussion, Mild that has completed, run by Huntington Medical Research Institutes. The registered enrollment target is 44 participants, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (78% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02069613, a study of Concussion, Mild, has completed, sponsored by Huntington Medical Research Institutes.

COMPLETED
Registry status
44 participants
Enrollment target
3
Study locations

Study Summary

The objective of the study is to determine the relative roles for various testing modalities in the diagnosis and prognosis of mild traumatic brain injury.

Conditions Studied

Study Locations (3)

California

  • Huntington Medical Research Institutes - Pasadena
  • HMRI - Pasadena
  • Molecular Neurology Program - Pasadena

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2014-03
Est. Completion 2017-08-01

What the Registry Record Tells You About NCT02069613

The ClinicalTrials.gov registry entry for NCT02069613 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (78% lower). The listed sponsor is Huntington Medical Research Institutes, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Concussion, Mild appearing as the primary indexed condition, and to 0 interventions.

NCT02069613 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02069613 about?

NCT02069613 is a clinical study titled "Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)". The objective of the study is to determine the relative roles for various testing modalities in the diagnosis and prognosis of mild traumatic brain injury.

What is the current status of trial NCT02069613?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2014-03. Estimated completion is 2017-08-01.

What conditions does trial NCT02069613 study?

This clinical trial studies the following conditions: Concussion, Mild.

Who is sponsoring clinical trial NCT02069613?

This trial is sponsored by Huntington Medical Research Institutes, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02069613 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion, Mild

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.